Paired VNS Therapy
Stroke Recovery Specialists
The Vivistim Paired VNS System (MicroTransponder Inc.) is an FDA-approved neuromodulation device for adults with moderate to severe upper limb motor deficits from ischemic stroke. A small pulse generator is implanted under the clavicle and delivers vagus nerve stimulation (VNS) paired precisely with each repetition of physical therapy exercises augmenting the brain’s plasticity during rehabilitation to drive greater recovery of arm and hand function than rehabilitation alone.
Key takeaways
- Vivistim is FDA-approved for adults with moderate to severe upper extremity motor deficits associated with chronic ischemic stroke.
- The device delivers brief vagus nerve stimulation bursts paired precisely with each repetition of rehabilitation exercises designed to enhance activity-dependent neuroplasticity during rehabilitation.
- The pivotal VNS-REHAB randomized controlled trial showed that Vivistim plus rehabilitation significantly outperformed sham stimulation plus rehabilitation for upper limb motor recovery.
- The implant is placed under general or local anesthesia as a brief outpatient procedure, a 30 to 45 minute operation.
- ABS coordinates with stroke neurology and rehabilitation medicine for patient selection and post-implant therapy programming.
| FDA approval | Adults with moderate to severe upper limb motor deficit from chronic ischemic stroke |
| Mechanism | VNS paired with each repetition of physical therapy augments cortical plasticity |
| Implant | Small pulse generator under left clavicle; lead to left vagus nerve in the neck |
| Therapy | Intensive VNS-paired rehabilitation sessions 3 days/week for 6 weeks in-clinic; continued at home |
| Surgery time | 30 to 45 minutes; outpatient procedure |
| Evidence | VNS-REHAB trial: significantly greater upper limb recovery vs. sham + rehabilitation |
| Best for | Chronic ischemic stroke with moderate to severe arm weakness; stable neurological status |
How Vivistim enhances stroke rehabilitation
After an ischemic stroke, the brain begins to reorganize by forming new connections that allow healthy areas to take over some functions previously performed by damaged tissue. This process, known as neuroplasticity, is the foundation of stroke rehabilitation. Rehabilitation exercises encourage these changes, but recovery often reaches a plateau despite continued therapy.
Vivistim is designed to enhance this process by pairing brief vagus nerve stimulation with rehabilitation exercises. Vagus nerve stimulation is believed to activate brain pathways that release neuromodulators such as norepinephrine and acetylcholine, making the brain more receptive to motor learning during therapy. In preclinical studies, pairing VNS with rehabilitation has been shown to enhance cortical reorganization compared with rehabilitation alone.
During supervised rehabilitation, stimulation is synchronized with therapist-guided exercises using the Vivistim therapy system. During the home exercise program, patients use a handheld magnet to activate stimulation while performing prescribed exercises. By repeatedly pairing stimulation with targeted movements, the therapy is designed to reinforce the neural pathways involved in arm and hand function.
Implantation and therapy protocol
The implant surgery is a 30 to 45 minute outpatient procedure under general or local anesthesia with sedation. A small incision is made below the left clavicle and a pulse generator is placed subcutaneously. A lead is tunneled up the neck to wrap around the left vagus nerve. The device is programmed and tested in the operating room.
Post-implant therapy begins 2 weeks after surgery (after wound healing) and consists of intensive VNS-paired rehabilitation sessions with a trained physical therapist 3 days per week for 6 weeks in the clinic. Each session involves approximately 400 repetitions of targeted arm and hand exercises paired with stimulation. Patients continue a home exercise program on non-clinic days.
Most patients notice meaningful upper limb improvement during or after the 6-week intensive program. The degree of improvement depends on stroke severity, time since stroke, and patient engagement with therapy.
Benefits and risks
Potential benefits
- FDA-approved treatment for a population with limited options for continued upper limb recovery
- Clinically meaningful improvement in arm and hand function shown in randomized controlled trial
- Outpatient implant procedure with rapid recovery
- Non-pharmacological no systemic drug side effects
Possible risks
- Implant site complications: infection, seroma, lead migration (low rates)
- Hoarseness or voice changes from vagal stimulation usually mild and dose-adjustable
- Swallowing difficulties in a small percentage of patients
- Not appropriate for hemorrhagic stroke, bilateral vagotomy, or cardiac pacemaker in some configurations
Your surgeon will review the benefits and risks specific to your diagnosis during your consultation.
What recovery looks like
Recovery from the implant itself is brief. The rehabilitation program is the central commitment:
- Surgery day Outpatient procedure. Small incision below the clavicle. Most patients go home the same day.
- Week 1 to 2 Wound healing. Activity restriction of the left shoulder. Device not yet activated.
- Weeks 2 to 8 Intensive in-clinic VNS-paired therapy 3 days/week. Home exercises on remaining days.
- Ongoing Home exercise program with the device continues after the in-clinic phase. Annual device check. Battery life approximately 3 to 5 years.
Frequently asked questions
Who is a candidate for Vivistim?
Adults with moderate to severe upper limb motor disability (Fugl-Meyer Upper Extremity score 20 to 50 out of 66) from a single ischemic stroke at least 9 months prior, who are medically stable, motivated to complete intensive rehabilitation, and do not have contraindications to VNS implantation. Hemorrhagic stroke, bilateral vagotomy, and severe dysphagia are contraindications.
How much improvement can I expect?
The VNS-REHAB trial showed a mean improvement in Fugl-Meyer score of approximately 5 points greater with Vivistim plus rehabilitation than with sham plus rehabilitation a statistically and clinically meaningful difference for a population that has typically plateaued with standard therapy. Individual responses vary; the most highly motivated patients who complete the full therapy protocol tend to achieve the greatest benefits.
Is Vivistim covered by insurance?
Coverage is expanding as the device is relatively new to market. Medicare and major commercial insurers are adding coverage. Prior authorization is required. The ABS team and MicroTransponder patient services can assist with insurance navigation.
Can Vivistim be combined with other stroke recovery treatments?
Yes. Vivistim is an adjunct to physical and occupational therapy it enhances the therapy that is already being done. It can be combined with constraint-induced movement therapy (CIMT), robotics-assisted therapy, and other evidence-based rehabilitation approaches. Your rehabilitation medicine team will design the optimal combined program.
This page is for general education and does not replace medical advice. Treatment decisions should be made with a qualified neurosurgeon based on your individual diagnosis and imaging. To discuss your options, call Atlantic Brain and Spine Vascular Neurosurgical Care at 973.993.7772 or request a consultation.
Neurovascular and Neuromodulation Specialists at Atlantic Brain and Spine
Your procedure is performed by fellowship-trained neurosurgeons working closely with rehabilitation specialists to help maximize upper extremity recovery after stroke.
